391 related articles for article (PubMed ID: 32821069)
1. Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations.
Mpilla GB; Philip PA; El-Rayes B; Azmi AS
World J Gastroenterol; 2020 Jul; 26(28):4036-4054. PubMed ID: 32821069
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic neuroendocrine tumors: Nosography, management and treatment.
Orditura M; Petrillo A; Ventriglia J; Diana A; Laterza MM; Fabozzi A; Savastano B; Franzese E; Conzo G; Santini L; Ciardiello F; De Vita F
Int J Surg; 2016 Apr; 28 Suppl 1():S156-62. PubMed ID: 26708853
[TBL] [Abstract][Full Text] [Related]
4. Gastroenteropancreatic neuroendocrine tumors: update on therapeutics.
Ganetsky A; Bhatt V
Ann Pharmacother; 2012 Jun; 46(6):851-62. PubMed ID: 22589450
[TBL] [Abstract][Full Text] [Related]
5. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
[No Abstract] [Full Text] [Related]
6. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
7. Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study.
Zhu LM; Tang L; Qiao XW; Wolin E; Nissen NN; Dhall D; Chen J; Shen L; Chi Y; Yuan YZ; Ben QW; Lv B; Zhou YR; Bai CM; Chen J; Song YL; Song TT; Lu CM; Yu R; Chen YJ
Medicine (Baltimore); 2016 Feb; 95(7):e2836. PubMed ID: 26886644
[TBL] [Abstract][Full Text] [Related]
8. The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
Ito T; Lee L; Hijioka M; Kawabe K; Kato M; Nakamura K; Ueda K; Ohtsuka T; Igarashi H
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):574-7. PubMed ID: 25689058
[TBL] [Abstract][Full Text] [Related]
9. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience.
Oleinikov K; Uri I; Jacob H; Epshtein J; Benson A; Ben-Haim S; Atlan K; Tal I; Meirovitz A; Maimon O; Lev-Cohain N; Mazeh H; Glaser B; Gross DJ; Grozinsky-Glasberg S
Endocrine; 2020 Apr; 68(1):222-229. PubMed ID: 32036501
[TBL] [Abstract][Full Text] [Related]
11. It's more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumors.
Underwood PW; Riner AN; Neal D; Cameron ME; Yakovenko A; Reddy S; Rose JB; Hughes SJ; Trevino JG
J Surg Oncol; 2021 Dec; 124(8):1390-1401. PubMed ID: 34499741
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic diagnosis and treatment of pancreatic neuroendocrine tumors.
Rustagi T; Farrell JJ
J Clin Gastroenterol; 2014; 48(10):837-44. PubMed ID: 24828360
[TBL] [Abstract][Full Text] [Related]
13. Gastroenteropancreatic Neuroendocrine Tumors.
Cives M; Strosberg JR
CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930
[TBL] [Abstract][Full Text] [Related]
14. Animal models of spontaneous pancreatic neuroendocrine tumors.
Yu R
Mol Cell Endocrinol; 2016 Feb; 421():60-7. PubMed ID: 26261055
[TBL] [Abstract][Full Text] [Related]
15. Recent Updates in the Management of Advanced Pancreatic Neuroendocrine Tumors.
Cho CM
Korean J Gastroenterol; 2019 Mar; 73(3):124-131. PubMed ID: 31013555
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.
Halfdanarson TR; Rabe KG; Rubin J; Petersen GM
Ann Oncol; 2008 Oct; 19(10):1727-33. PubMed ID: 18515795
[TBL] [Abstract][Full Text] [Related]
17. Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).
Jung JG; Lee KT; Woo YS; Lee JK; Lee KH; Jang KT; Rhee JC
Medicine (Baltimore); 2015 Jul; 94(26):e983. PubMed ID: 26131843
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumors: a review.
Young K; Iyer R; Morganstein D; Chau I; Cunningham D; Starling N
Future Oncol; 2015; 11(5):853-64. PubMed ID: 25757686
[TBL] [Abstract][Full Text] [Related]
19. Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.
Singh S; Dey C; Kennecke H; Kocha W; Maroun J; Metrakos P; Mukhtar T; Pasieka J; Rayson D; Rowsell C; Sideris L; Wong R; Law C
Ann Surg Oncol; 2015 Aug; 22(8):2685-99. PubMed ID: 25366583
[TBL] [Abstract][Full Text] [Related]
20. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.
Mauriello C; Napolitano S; Gambardella C; Candela G; De Vita F; Orditura M; Sciascia V; Tartaglia E; Lanza M; Santini L; Conzo G
Int J Surg; 2015 Sep; 21 Suppl 1():S10-4. PubMed ID: 26118605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]